Tumour-on-a-chip offers insight into cancer-targeting cells in immunotherapy
For a little over two decades, chimaeric antigen receptor (CAR) T cell therapy has emerged…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Engineering extracellular vesicles
In the quest for more targeted lung cancer treatments, a researcher at the University of…
Molecular insights and targeted therapies are transforming breast cancer treatment
Breast cancer remains the most prevalent cancer in women and the leading cause of cancer-related…
Researchers uncover key mechanism behind chemotherapy-induced nerve damage
Scientists have made a breakthrough in understanding why many cancer patients develop nerve damage after…
Long-term European study confirms PSA screening saves lives, deaths from prostate cancer 13% lower after 23 years
A landmark European study has found that regular prostate-specific antigen (PSA) screening can significantly reduce…
Capturing cancer cells from blood could guide breast cancer treatment decisions
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and…
Study challenges conventional wisdom on a common cause of melanoma
University of Queensland researchers have found that a genetic mutation that causes melanoma can lie…
New roadmap aims to change the story for the most lethal gynaecological cancer
The Ovarian Cancer Research Foundation (OCRF) has launched an ambitious five-year Research Impact Strategy to…
Should H. pylori be treated in children to prevent gastric cancer?
A new JAMA Pediatrics Viewpoint argues that Helicobacter pylori infection in children should be routinely…
RANZCR 2025: Medical specialists converge to examine Australian radiotherapy breakthrough
Australian researchers last night revealed human clinical data for a world-first pan-cancer biomarker assay, RadnostTM,…